Dr. Swati Sehgal
Overview
Swati Sehgal is a Hematologist and an Oncologist in Mount Kisco, New York. Dr. Sehgal is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Familial Pancreatic Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 East Main Street, Mount Kisco, NY 10549
Additional Areas of Focus
Dr. Sehgal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Icahn School Of Medicine At Mount Sinai
Joshua Richter is an Oncologist and a Hematologist in New York, New York. Dr. Richter is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Secondary Immunodeficiency (SID), Bone Marrow Transplant, and Bone Marrow Aspiration.
Regional Cancer Care Associates LLC
David Siegel is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Siegel is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Plasmacytoma, and Bone Marrow Transplant.
Icahn School Of Medicine At Mount Sinai
Sundar Jagannath is an Oncologist in New York, New York. Dr. Jagannath is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Plasmacytoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AnemiaDr. Sehgal isAdvanced. Learn about Anemia.
- Colorectal CancerDr. Sehgal isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Sehgal isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Sehgal isAdvanced. Learn about Familial Pancreatic Cancer.
- Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
- GTP Cyclohydrolase 1 DeficiencyDr. Sehgal isAdvanced. Learn about GTP Cyclohydrolase 1 Deficiency.
- Experienced
- Acute Mountain SicknessDr. Sehgal isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Sehgal isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Sehgal isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AngiosarcomaDr. Sehgal isExperienced. Learn about Angiosarcoma.
- Arterial EmbolismDr. Sehgal isExperienced. Learn about Arterial Embolism.
- Breast CancerDr. Sehgal isExperienced. Learn about Breast Cancer.